β2-Adaptin Activators are compounds that, while not directly activating β2-Adaptin, might influence its activity indirectly. These compounds primarily affect cellular phosphorylation status, thereby potentially influencing the function of β2-Adaptin as part of the AP-1 complex. For instance, PKC Activator enhances PKC-mediated phosphorylation, a key regulatory mechanism for AP-1 complex function. Thus, it can indirectly influence β2-Adaptin.
Forskolin and IBMX both influence the cAMP pathway, with Forskolin activating adenylate cyclase to increase cAMP levels and IBMX inhibiting phosphodiesterases to prevent cAMP degradation. The elevated cAMP levels can activate PKA, which in turn can modulate the phosphorylation status of proteins, potentially affecting β2-Adaptin. Conversely, Calyculin A and Okadaic Acid inhibit protein phosphatases PP1 and PP2A, preventing protein dephosphorylation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin activates adenylate cyclase, increasing the levels of cyclic AMP (cAMP) in cells. cAMP can activate PKA, which in turn can modulate the phosphorylation status of proteins, potentially affecting β2-Adaptin. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that degrade cAMP. By increasing cAMP concentration, it indirectly affects PKA activity and could influence the phosphorylation status of β2-Adaptin. | ||||||